Tony King, Author at Daily Investor Hub

The global real-world evidence solutions market is expected to expand at a steady CAGR over the forecast period.

September 5, 2024September 6, 2024Tony KingLeave a Comment

The rising support for RWE adoption from regulatory bodies, more financing from pharmaceutical firms, and the extra insights obtained over randomized clinical trials (RCTs) are driving the expansion of the worldwide market for real-world evidence solutions. Real-world evidence (RWE) is the clinical evidence regarding usage and potential benefits/risks of a medical product based on analysis […]

Global flow cytometry market is predicted to increase at an 8% rate, reaching over $11 billion.

September 4, 2024Tony KingLeave a Comment

Some of the major factors propelling the market growth are the high incidence and prevalence of cancer and HIV/AIDS, the growing emphasis on immunology and immuno-oncology research, the introduction of AI platforms in flow cytometry workflows, and the rise in R&D spending to create multicolor assays and cutting-edge reagents. The increased price of flow cytometry […]

Global IVD Contract Manufacturing Services Market, which was valued at $4.6 billion in 2021, is expected to increase at a 4% annual pace through 2026.

September 4, 2024Tony KingLeave a Comment

Growing demand for point-of-care (POC) testing services, the Covid-19 outbreak, government support to increase IVD kit production, the rising incidence of cancer and infectious diseases, cost savings, scalability, technology know-how, and risk mitigation provided by IVD contract manufacturers are among the key factors driving market growth. In-vitro diagnostics (IVD) are tests done on samples such […]

Global Cell and Gene Therapy CDMO market is expected to grow at a CAGR of over 25%, reaching $5 billion by 2025.

September 4, 2024Tony KingLeave a Comment

Driven by the rising incidence of cancer and other targeted illnesses, the robust CGT pipeline, the fast-growing field of cell and gene therapy research, significant venture capital financing, and technical advancements. The development and approval of CAR-T cell therapies such as Kymriah and Yescarta and their success in combating hematological malignancies, has further boosted investment in CGT. Robust CGT pipeline with growing number of product approvals, strong support from large pharma and biotech, and consistent investor enthusiasm (~$20 bn raised in 2020) is set […]

The Digital Pathology Market is expected to witness a steady CAGR of ~10.5% by 2029.

September 4, 2024Tony KingLeave a Comment

The primary drivers of this market are the increasing prevalence of chronic diseases such as diabetes, cancer, and cardiovascular disorders; the growing use of digital pathology in research; the increasing incorporation of digital pathology in drug discovery and precision medicine programs; the growing acceptance of telepathology; and the adoption of digital pathology to improve efficiency […]

The Patient Engagement Solutions Market is expected to grow at a robust CAGR of 13-17% in the coming years.

September 4, 2024Tony KingLeave a Comment

Due to rising demand for patient-centered treatment and fast technology improvements. Furthermore, the trend toward preventative healthcare efforts and value-based care models accelerates the adoption of patient engagement solutions, fueling innovation and growth in the healthcare industry. Patient engagement solutions are a multidimensional strategy that uses digital advances and customized techniques to actively engage patients […]

Global Nanopore Sequencing Market, which was valued at $200 million in 2021, is expected to increase at a 26% annual pace through 2026.

September 2, 2024Tony KingLeave a Comment

Some of the main drivers propelling the market expansion include the benefits of nanopore sequencing, which include high throughput and ultra-long reads; technical breakthroughs in nanopore technologies; increased expenditures in R&D; and the increasing occurrence of infectious illnesses. Nanopore Sequencing, a fourth-generation sequencing technology, in which single strands of DNA or RNA are passed through […]

Global Digital Behavioral/Mental Health Market is poised to observe an exponential growth rate of 25% by 2026

September 2, 2024Tony KingLeave a Comment

Some of the main reasons propelling the market growth are Covid-19, the rising prevalence of mental health illnesses, the use of personal digital devices, a supportive financing environment, and the expansion of the healthcare IT infrastructure in both developed and developing nations. However, issues with patient privacy and the lack of qualified HCIT specialists would […]

Global clinical trial supplies market is valued at $2.5 billion in 2021 and is projected to grow at a CAGR of 8% by 2026

September 2, 2024Tony KingLeave a Comment

Caused by rising R&D costs, more complex clinical trials and regulations, a thriving biotech venture capital industry, a tendency toward outsourcing, and an increase in the number of clinical studies carried out. The clinical trial supplies (CTS) market includes services like packaging and labeling services, clinical supplies logistics & distribution, comparator sourcing, and clinical supplies […]

The $2.25 billion global single-use assemblies market is expected to increase at a healthy rate of 22% by 2026.

September 2, 2024Tony KingLeave a Comment

Some of the main drivers propelling the market growth are the benefits of ready-to-use single-use assembly, the availability of financing for the production of single-use solutions, the expansion of the biologics and vaccines industry, and the rise in biopharmaceutical R&D. A single-use assembly is a ready-to-use custom-made all-in-one solution made from different plastic components that […]